PartsTable
Technical Data Sheet
Download PDF

1708630 — CORONAVIRUS VACCINE

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

1708630: CORONAVIRUS VACCINE.

The CORONAVIRUS VACCINE is a the manufacturer industrial component. Key specifications include virus_strain: COVID-19, primary_container_type: SYRINGE, primary_container_content_quantity: 0.5 MILLILITERS, part_name_assigned_by_controlling_agency: NOVAVAX, ADJUVANTED, PRE-FILLED SYRINGES 0.5ML, 10S, 2025-2026 FORMULA.. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-734-2820, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
1708630
NSN: 6505-01-734-2820
FSC: 6505 — Drugs and Biologicals
CAGE: 89875 — DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA (USA)
SPECIFICATIONS
virus_strainCOVID-19
primary_container_typeSYRINGE
primary_container_content_quantity0.5 MILLILITERS
part_name_assigned_by_controlling_agencyNOVAVAX, ADJUVANTED, PRE-FILLED SYRINGES 0.5ML, 10S, 2025-2026 FORMULA.
NSN6505-01-734-2820
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CORONAVIRUS VACCINE TITLE COMPONENT PN 1708630 MFR CORONAVIRUS VACCINE
KEY FEATURES
•
PRIMARY CONTAINER CONTENT QUANTITY: 0.5 MILLILITERS
•
VIRUS STRAIN: COVID-19
•
PRIMARY CONTAINER TYPE: SYRINGE
TECHNICAL CHARACTERISTICS
PRIMARY CONTAINER CONTENT QUANTITY0.5 MILLILITERS
VIRUS STRAINCOVID-19
PRIMARY CONTAINER TYPESYRINGE
SPECIAL FEATURESINDICATED FOR ACTIVE IMMUNIZATION TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARSCOV-2) IN INDIVIDUALS 65 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE AND OLDER, OR 12 YEARS THROUGH 64 YEARS OF AGE WITH AT LEAST ONE UNDERLYING CONDITION THAT PUTS THEM AT HIGH RISK FOR SEVERE OUTCOMES FROM COVID-19; FOR INTRAMUSCULAR USE; CARTON OF 10 SINGLE-DOSE PRE-FILLED SYRINGES, EACH SYRINGE CONTAINS 1 DOSE OF 0.5 ML; STORE IN A REFRIGERATOR AT 2C TO 8C (36F TO 46F). DO NOT FREEZE; STORE IN THE ORIGINAL CARTON TO PROTECT FROM LIGHT.; 2025-2026 FORMULA; CONTAINS NO PRESERVATIVE.
PART NAME ASSIGNED BY CONTROLLING AGENCYNOVAVAX, ADJUVANTED, PRE-FILLED SYRINGES 0.5ML, 10S, 2025-2026 FORMULA.
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
6505NCM252091Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
No demilitarization required
Ready to buy 1708630?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 1708630?
1708630 is a CORONAVIRUS VACCINE.
What parts can replace 1708630?
There is 1 known substitute for 1708630: 6505NCM252091. Substitute compatibility should be verified for your specific system.
What is the NSN for 1708630?
1708630 is cataloged in the U.S. Government catalog under NSN 6505-01-734-2820. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 1708630